This webcast is not yet available for viewing.
The program was captured live at the NACE Emerging Challenges in Primary Casre: Update 2007 series and features Dr. Patrick Boyle. Dr. Boyle is Professor of Medicine at the University of New Mexico. Please visit www.naceonline.com for more information.
Learning Objective
Our learning objective for this webcast is to discuss glycemic and cardiovascular outcomes from insulin trials in type 2 diabetes, and optimize glycemic control with insulin in type 2 diabetes while minimizing weight gain and hypoglycemia.
Faculty Disclosure
Dr. Boyle is on the speaker's bureau for Eli Lilly and Company, Pfizer, Amylin, Merck, and Takeda Pharmaceuticals of North America.
